590 related articles for article (PubMed ID: 25977370)
1. Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.
Bell RJ; Rube HT; Kreig A; Mancini A; Fouse SD; Nagarajan RP; Choi S; Hong C; He D; Pekmezci M; Wiencke JK; Wrensch MR; Chang SM; Walsh KM; Myong S; Song JS; Costello JF
Science; 2015 May; 348(6238):1036-9. PubMed ID: 25977370
[TBL] [Abstract][Full Text] [Related]
2. An interaction proteomics survey of transcription factor binding at recurrent TERT promoter mutations.
Makowski MM; Willems E; Fang J; Choi J; Zhang T; Jansen PW; Brown KM; Vermeulen M
Proteomics; 2016 Feb; 16(3):417-26. PubMed ID: 26553150
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner.
Mancini A; Xavier-Magalhães A; Woods WS; Nguyen KT; Amen AM; Hayes JL; Fellmann C; Gapinske M; McKinney AM; Hong C; Jones LE; Walsh KM; Bell RJA; Doudna JA; Costa BM; Song JS; Perez-Pinera P; Costello JF
Cancer Cell; 2018 Sep; 34(3):513-528.e8. PubMed ID: 30205050
[TBL] [Abstract][Full Text] [Related]
4. Cancer-specific loss of
Amen AM; Fellmann C; Soczek KM; Ren SM; Lew RJ; Knott GJ; Park JE; McKinney AM; Mancini A; Doudna JA; Costello JF
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33758097
[TBL] [Abstract][Full Text] [Related]
5. GABP couples oncogene signaling to telomere regulation in TERT promoter mutant cancer.
McKinney AM; Mathur R; Stevers NO; Molinaro AM; Chang SM; Phillips JJ; Costello JF
Cell Rep; 2022 Sep; 40(12):111344. PubMed ID: 36130485
[TBL] [Abstract][Full Text] [Related]
6. TERT promoter mutations and GABP transcription factors in carcinogenesis: More foes than friends.
Yuan X; Dai M; Xu D
Cancer Lett; 2020 Nov; 493():1-9. PubMed ID: 32768523
[TBL] [Abstract][Full Text] [Related]
7. TERT Promoter Mutations Enhance Telomerase Activation by Long-Range Chromatin Interactions.
Min J; Shay JW
Cancer Discov; 2016 Nov; 6(11):1212-1214. PubMed ID: 27807101
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Allele-Specific Regulation of Telomerase Reverse Transcriptase in Promoter Mutant Thyroid Cancer Cell Lines.
McKelvey BA; Gilpatrick T; Wang Y; Timp W; Umbricht CB; Zeiger MA
Thyroid; 2020 Oct; 30(10):1470-1481. PubMed ID: 32228178
[No Abstract] [Full Text] [Related]
9. Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.
Stern JL; Theodorescu D; Vogelstein B; Papadopoulos N; Cech TR
Genes Dev; 2015 Nov; 29(21):2219-24. PubMed ID: 26515115
[TBL] [Abstract][Full Text] [Related]
10. Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer.
Barger CJ; Suwala AK; Soczek KM; Wang AS; Kim MY; Hong C; Doudna JA; Chang SM; Phillips JJ; Solomon DA; Costello JF
Nat Commun; 2022 Sep; 13(1):5430. PubMed ID: 36114166
[TBL] [Abstract][Full Text] [Related]
11. Characterization of human telomerase reverse transcriptase promoter methylation and transcription factor binding in differentiated thyroid cancer cell lines.
Avin BA; Wang Y; Gilpatrick T; Workman RE; Lee I; Timp W; Umbricht CB; Zeiger MA
Genes Chromosomes Cancer; 2019 Aug; 58(8):530-540. PubMed ID: 30664813
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic targeting of FOS in mutant
Liu R; Tan J; Shen X; Jiang K; Wang C; Zhu G; Xing M
Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836600
[TBL] [Abstract][Full Text] [Related]
13. Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region.
Li CL; Li CY; Lin YY; Ho MC; Chen DS; Chen PJ; Yeh SH
Hepatology; 2019 Feb; 69(2):498-512. PubMed ID: 30070724
[TBL] [Abstract][Full Text] [Related]
14. GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.
Yuan X; Mu N; Wang N; Strååt K; Sofiadis A; Guo Y; Stenman A; Li K; Cheng G; Zhang L; Kong F; Ekblad L; Wennerberg J; Nilsson IL; Juhlin CC; Larsson C; Xu D
Oncogene; 2019 Feb; 38(7):965-979. PubMed ID: 30181547
[TBL] [Abstract][Full Text] [Related]
15. Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Liu R; Zhang T; Zhu G; Xing M
Nat Commun; 2018 Feb; 9(1):579. PubMed ID: 29422527
[TBL] [Abstract][Full Text] [Related]
16. Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.
Li Y; Zhou QL; Sun W; Chandrasekharan P; Cheng HS; Ying Z; Lakshmanan M; Raju A; Tenen DG; Cheng SY; Chuang KH; Li J; Prabhakar S; Li M; Tergaonkar V
Nat Cell Biol; 2015 Oct; 17(10):1327-38. PubMed ID: 26389665
[TBL] [Abstract][Full Text] [Related]
17. TERT promoter alterations could provide a solution for Peto's paradox in rodents.
Vedelek B; Maddali AK; Davenova N; Vedelek V; Boros IM
Sci Rep; 2020 Nov; 10(1):20815. PubMed ID: 33257697
[TBL] [Abstract][Full Text] [Related]
18. Long-Range Chromatin Interactions Drive Mutant TERT Promoter Activation.
Akıncılar SC; Khattar E; Boon PL; Unal B; Fullwood MJ; Tergaonkar V
Cancer Discov; 2016 Nov; 6(11):1276-1291. PubMed ID: 27650951
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for reactivating the mutant TERT promoter by cooperative binding of p52 and ETS1.
Xu X; Li Y; Bharath SR; Ozturk MB; Bowler MW; Loo BZL; Tergaonkar V; Song H
Nat Commun; 2018 Aug; 9(1):3183. PubMed ID: 30093619
[TBL] [Abstract][Full Text] [Related]
20. Brain regions associated with telomerase reverse transcriptase promoter mutations in primary glioblastomas.
Fan X; Wang Y; Liu Y; Liu X; Zhang C; Wang L; Li S; Ma J; Jiang T
J Neurooncol; 2016 Jul; 128(3):455-62. PubMed ID: 27230769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]